Aridis Pharmaceuticals, Inc.
ARDSDelisted Sep 8, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001614067
Aridis Pharmaceuticals, Inc. was delisted on Sep 8, 2023; its insiders filed their last Form 4 on Jun 28, 2024; 18 institutions reported holding it in 13F filings for Q2 2023, worth $392.3K in total; no superinvestor held it.
13F holders, Q1 2023
Institutional positions in Aridis Pharmaceuticals, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- +3 vs. Q4 2022
- Shares held
- 4.13M
- +244.2K (+6.3%) vs. Q4 2022
- Total value
- $1.29M
- −$3.29M (−71.7%) vs. Q4 2022
- New holders
- 6
- 2 more added
- Sold out
- 3
- 5 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ARDS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $0 |
| Q1 2026 | 1 | $1 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 1 | $3 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 2 | $10 |
| Q3 2023 | 1 | $1.44K |
| Q2 2023 | 18 | $392.3K |
| Q1 2023 | 20 | $1.29M |
| Q4 2022 | 17 | $4.58M |
| Q3 2022 | 16 | $1.79M |
| Q2 2022 | 19 | $2.05M |
| Q1 2022 | 22 | $3.38M |
| Q4 2021 | 20 | $2.96M |
| Q3 2021 | 18 | $7.33M |
| Q2 2021 | 13 | $7.87M |
| Q1 2021 | 12 | $5.97M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Aridis Pharmaceuticals, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Sabby Management, LLC | 2,140,174 | $672.2K | 2.50% | +2,140,174 | New |
| Commonwealth Equity Services, LLC | 646,000 | $202.0K | 0.00% | +71,000+12.3% | Added |
| Vanguard Group Inc | 525,156 | $165.0K | 0.00% | +703+0.1% | Added |
| Roumell Asset Management, LLC | 446,588 | $140.3K | 0.32% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 143,034 | $44.9K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 43,247 | $13.6K | 0.00% | 00.0% | Unchanged |
| Prudential Financial Inc | 37,600 | $11.8K | 0.00% | +37,600 | New |
| Acadian Asset Management LLC | 36,533 | $11.0K | 0.00% | +36,533 | New |
| Northern Trust Corp | 28,104 | $8.83K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 23,082 | $7.25K | 0.00% | +23,082 | New |
| HRT Financial LP | 17,227 | $5.00K | 0.00% | +17,227 | New |
| Jane Street Group, LLC | 15,356 | $4.82K | 0.00% | +15,356 | New |
| Wealth Architects, LLC | 14,077 | $4.42K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 4,612 | $1.45K | 0.00% | −12,651−73.3% | Reduced |
| UBS Group AG | 2,683 | $842 | 0.00% | −4,985−65.0% | Reduced |
| Wells Fargo & Company | 1,354 | $426 | 0.00% | −24−1.7% | Reduced |
| Group One Trading, L.P. | 1,237 | $389 | 0.00% | −1,965−61.4% | Reduced |
| ICA Group Wealth Management, LLC | 250 | $79 | 0.00% | 00.0% | Unchanged |
| Financial Perspectives, Inc | 250 | $79 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,584 | $0 | 0.00% | −8,046−83.6% | Reduced |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −2,068,000−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −1,719−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −40−100.0% | Sold out |